Literature DB >> 4031036

Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

C N Baker, D G Hollis, C Thornsberry.   

Abstract

A modified Mueller-Hinton broth was developed to perform antimicrobial susceptibility tests on Francisella tularensis. Adequate growth of the organism was obtained within 24 h of inoculation, and MICs could be read at that time. We tested 15 selected strains of F. tularensis and five reference quality control strains in this medium with 36 antimicrobial agents. The MICs of the aminoglycosides and tetracycline increased 1 to 3 dilutions in this medium compared with those in the usual medium, but the other antimicrobial agents were not consistently affected by the medium. Even though the medium caused an increase in MICs, the aminoglycosides and tetracyclines remained very active in vitro against F. tularensis. Other antimicrobial agents effective in vitro were chloramphenicol, erythromycin, ceftazidime, moxalactam, cefotaxime, ceftriaxone, and Sch 29482 (a cephalosporin).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031036      PMCID: PMC268361          DOI: 10.1128/jcm.22.2.212-215.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The Morphology of Bacterium tularense.

Authors:  W Hesselbrock; L Foshay
Journal:  J Bacteriol       Date:  1945-03       Impact factor: 3.490

2.  Fermentation of Sugars by Bacterium Tularense.

Authors:  E Francis
Journal:  J Bacteriol       Date:  1942-03       Impact factor: 3.490

3.  Further studies on tularemia in the Ozarks; review of forty-four cases during a three-year period.

Authors:  W C CORWIN; S P STUBBS
Journal:  J Am Med Assoc       Date:  1952-05-24

4.  Studies on the variation of Bacterium tularense.

Authors:  H T EIGELSBACH; W BRAUN; R D HERRING
Journal:  J Bacteriol       Date:  1951-05       Impact factor: 3.490

5.  Tularemia epidemia: Vermont, 1968. Forty-seven cases linked to contact with muskrats.

Authors:  L S Young; D S Bickness; B G Archer; J M Clinton; L J Leavens; J C Feeley; P S Brachman
Journal:  N Engl J Med       Date:  1969-06-05       Impact factor: 91.245

6.  Culture of P. tularensis in the 1966-67 outbreaks of tularemia in Sweden. Laboratory methods and precautions against laboratory infections.

Authors:  O Ringertz; S Dahlstrand
Journal:  Acta Pathol Microbiol Scand       Date:  1968

7.  Growth and metabolism of live vaccine strain of Pasteurella tularensis.

Authors:  J M Scharer; F Klein; R E Lincoln
Journal:  Appl Microbiol       Date:  1968-06

8.  Isolation of Francisella tularensis from infected frozen human blood.

Authors:  B Pittman; E B Shaw; W B Cherry
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

9.  Infraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin.

Authors:  N G Olsufjev; I S Meshcheryakova
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1982

10.  Treatment of tularemia, including pulmonary tularemia, with gentamicin.

Authors:  W L Mason; H T Eigelsbach; S F Little; J H Bates
Journal:  Am Rev Respir Dis       Date:  1980-01
View more
  50 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Treatment of tularemia with ciprofloxacin.

Authors:  O Scheel; R Reiersen; T Hoel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

3.  Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.

Authors:  Steven D Brown; Karen Krisher; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis.

Authors:  Jason R Wickstrum; Kee-Jong Hong; Sirosh Bokhari; Natalie Reed; Nicholas McWilliams; Rebecca T Horvat; Michael J Parmely
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

5.  In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.

Authors:  Sandra K Urich; Jeannine M Petersen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

6.  Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Authors:  Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

7.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Authors:  Susan Twine; Mona Byström; Wangxue Chen; Mats Forsman; Igor Golovliov; Anders Johansson; John Kelly; Helena Lindgren; Kerstin Svensson; Carl Zingmark; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

Authors:  T R Rhinehart-Jones; A H Fortier; K L Elkins
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules.

Authors:  A H Fortier; T Polsinelli; S J Green; C A Nacy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.

Authors:  Jennifer C Chase; Jean Celli; Catharine M Bosio
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.